C6ORF170 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.326600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.614400E-01
Normal-vs-Stage2
3.994600E-01
Normal-vs-Stage3
9.784900E-03
Normal-vs-Stage4
1.985640E-01
Stage1-vs-Stage2
2.082800E-01
Stage1-vs-Stage3
7.626200E-02
Stage1-vs-Stage4
3.808000E-01
Stage2-vs-Stage3
1.123920E-03
Stage2-vs-Stage4
1.066380E-02
Stage3-vs-Stage4
1.819660E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.751800E-01
Normal-vs-AfricanAmerican
3.816200E-01
Normal-vs-Asian
1.337170E-01
Caucasian-vs-AfricanAmerican
9.809000E-01
Caucasian-vs-Asian
1.157830E-01
AfricanAmerican-vs-Asian
2.750400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.401200E-01
Normal-vs-Female
5.530600E-01
Male-vs-Female
3.507200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.663400E-01
Normal-vs-Age(41-60Yrs)
6.745000E-01
Normal-vs-Age(61-80Yrs)
3.355600E-01
Normal-vs-Age(81-100Yrs)
3.209000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.626200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.967600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.194600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.141820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.459000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.225600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.495790E-01
Normal-vs-Daily Drinker
1.181990E-01
Normal-vs-Weekly Drinker
2.234400E-01
Normal-vs-Occasional Drinker
8.399400E-01
Normal-vs-Social Drinker
9.536200E-01
Non Drinker-vs-Daily Drinker
7.838400E-01
Non Drinker-vs-Weekly Drinker
9.997000E-01
Non Drinker-vs-Occasional Drinker
2.634200E-02
Non Drinker-vs-Social Drinker
1.582230E-01
Daily Drinker-vs-Weekly Drinker
8.298200E-01
Daily Drinker-vs-Occasional Drinker
2.189800E-02
Daily Drinker-vs-Social Drinker
1.286810E-01
Weekly Drinker-vs-Occasional Drinker
8.445900E-02
Weekly Drinker-vs-Social Drinker
1.896610E-01
Occasional Drinker-vs-Social Drinker
8.995400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.980300E-02
Normal-vs-Grade 2
5.127700E-02
Normal-vs-Grade 3
2.646500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.011800E-01
Grade 1-vs-Grade 3
1.501810E-01
Grade 1-vs-Grade 4
7.980300E-02
Grade 2-vs-Grade 3
4.075400E-01
Grade 2-vs-Grade 4
5.127700E-02
Grade 3-vs-Grade 4
2.646500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.023200E-01
Normal-vs-NonDiabetic
2.476400E-01
Diabetic-vs-NonDiabetic
9.437800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.631500E-02
Normal-vs-NoPancreatitis
3.094200E-01
Pancreatitis-vs-NoPancreatitis
3.241400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.215600E-01
Normal-vs-N1
3.500000E-01
N0-vs-N1
4.621600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.705000E-01
Normal-vs-TP53-NonMutant
8.243000E-01
TP53-Mutant-vs-TP53-NonMutant
1.821050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
